Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Cyclooxygenase 2 augments osteoblastic but suppresses chondrocytic differentiation of CD90+ skeletal stem cells in fracture sites.

Wasnik S, Lakhan R, Baylink DJ, Rundle CH, Xu Y, Zhang J, Qin X, Lau KW, Carreon EE, Tang X.

Sci Adv. 2019 Jul 31;5(7):eaaw2108. doi: 10.1126/sciadv.aaw2108. eCollection 2019 Jul.

2.

Substance Use Disorder in People with Intellectual Disabilities: Current Challenges in Low- and Middle-Income Countries.

Lakhan R, Sagiraju HKR, Ekúndayò O, Sharma M.

J Neurosci Rural Pract. 2019 Apr-Jun;10(2):301-305. doi: 10.4103/jnrp.jnrp_393_18. Review.

3.

Epilepsy, Behavioral Problems, and Intellectual Disability among Children in India: Conundrums and Challenges.

Lakhan R, Ekúndayò OT, Sharma M.

J Neurosci Rural Pract. 2018 Jan-Mar;9(1):1-2. doi: 10.4103/jnrp.jnrp_477_17. No abstract available.

4.

Perceptions and Practices of the Iranian Population regarding Skin Cancers: A Literature Review.

Nahar VK, Hasani Z, Martin B, Boyas JF, Chabok R, Philip LS, Ghafari G, Seidfaraji L, Chelf S, Lakhan R, Wilkerson AH, Savoy M, Sharma M.

J Skin Cancer. 2017;2017:4934108. doi: 10.1155/2017/4934108. Epub 2017 Nov 19. Review.

5.

A Family Study of Consanguinity in Children with Intellectual Disabilities in Barwani, India.

Lakhan R, Bipeta R, Yerramilli SSRR, Nahar VK.

J Neurosci Rural Pract. 2017 Oct-Dec;8(4):551-555. doi: 10.4103/jnrp.jnrp_104_17.

6.

Important Research Priorities in Intellectual Disability in India: A Public Health Perspective.

Lakhan R, Ekúndayò OT.

J Neurosci Rural Pract. 2017 Aug;8(Suppl 1):S150-S151. doi: 10.4103/jnrp.jnrp_102_17. No abstract available.

7.

Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3.

Lakhan R, Subramanian VS, Said HM.

Am J Physiol Gastrointest Liver Physiol. 2017 Dec 1;313(6):G589-G598. doi: 10.1152/ajpgi.00238.2017. Epub 2017 Sep 14.

8.

The National Trust: A viable model of care for adults with intellectual disabilities in India.

Menon DK, Kishore MT, Sivakumar T, Maulik PK, Kumar D, Lakhan R, Banerjee R.

J Intellect Disabil. 2017 Sep;21(3):259-269. doi: 10.1177/1744629517709832.

PMID:
28812964
9.

Unique Regenerative Mechanism to Replace Bone Lost During Dietary Bone Depletion in Weanling Mice.

Sheng MH, Lau KW, Lakhan R, Ahmed ASI, Rundle CH, Biswanath P, Baylink DJ.

Endocrinology. 2017 Apr 1;158(4):714-729. doi: 10.1210/en.2016-1379.

PMID:
28324039
10.

Lipopolysaccharide inhibits colonic biotin uptake via interference with membrane expression of its transporter: a role for a casein kinase 2-mediated pathway.

Lakhan R, Said HM.

Am J Physiol Cell Physiol. 2017 Apr 1;312(4):C376-C384. doi: 10.1152/ajpcell.00300.2016. Epub 2017 Jan 4.

11.
12.

Down syndrome in tribal population in India: A field observation.

Lakhan R, Kishore MT.

J Neurosci Rural Pract. 2016 Jan-Mar;7(1):40-3. doi: 10.4103/0976-3147.172167.

13.

An estimation of the prevalence of intellectual disabilities and its association with age in rural and urban populations in India.

Lakhan R, Ekúndayò OT, Shahbazi M.

J Neurosci Rural Pract. 2015 Oct-Dec;6(4):523-8. doi: 10.4103/0976-3147.165392.

14.

Profile of Social, Environmental and Biological Correlates in Intellectual Disability in A Resource-Poor Setting in India.

Lakhan R.

Indian J Psychol Med. 2015 Jul-Sep;37(3):311-6. doi: 10.4103/0253-7176.162957.

15.

Local administration of AAV-DJ pseudoserotype expressing COX2 provided early onset of transgene expression and promoted bone fracture healing in mice.

Lakhan R, Baylink DJ, Lau KH, Tang X, Sheng MH, Rundle CH, Qin X.

Gene Ther. 2015 Sep;22(9):721-8. doi: 10.1038/gt.2015.40. Epub 2015 Apr 28.

PMID:
25965395
16.

Identifying Children with Intellectual Disabilities in the Tribal Population of Barwani District in State of Madhya Pradesh, India.

Lakhan R, Mawson AR.

J Appl Res Intellect Disabil. 2016 May;29(3):211-9. doi: 10.1111/jar.12171. Epub 2015 Mar 31.

PMID:
25832547
17.

National sample survey organization survey report: An estimation of prevalence of mental illness and its association with age in India.

Lakhan R, Ekúndayò OT.

J Neurosci Rural Pract. 2015 Jan;6(1):51-4. doi: 10.4103/0976-3147.143194.

18.

Community-Based Rehabilitation is an Option to Address Challenges of Disabilities in India.

Lakhan R.

J Family Med Prim Care. 2014 Jul;3(3):293. doi: 10.4103/2249-4863.141659. No abstract available.

19.

Behavioral management in children with intellectual disabilities in a resource-poor setting in Barwani, India.

Lakhan R.

Indian J Psychiatry. 2014 Jan;56(1):39-45. doi: 10.4103/0019-5545.124712.

20.

Intelligence quotient is associated with epilepsy in children with intellectual disability in India.

Lakhan R.

J Neurosci Rural Pract. 2013 Oct;4(4):408-12. doi: 10.4103/0976-3147.120241.

21.
22.

SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.

Kumari R, Lakhan R, Kumar S, Garg RK, Misra UK, Kalita J, Mittal B.

Biochimie. 2013 Jun;95(6):1350-3. doi: 10.1016/j.biochi.2013.02.006. Epub 2013 Mar 1.

PMID:
23466530
23.

Influence of Bcl-1 Gene Polymorphism of Glucocorticoid Receptor Gene (NR3C1, rs41423247) on Blood Pressure, Glucose in Northern Indians.

Srivastava N, Prakash J, Lakhan R, Agarwal CG, Pant DC, Mittal B.

Indian J Clin Biochem. 2011 Apr;26(2):125-30. doi: 10.1007/s12291-010-0099-6. Epub 2011 Jan 13.

24.

Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy.

Lakhan R, Kumari R, Singh K, Kalita J, Misra UK, Mittal B.

Indian J Med Res. 2011 Sep;134:295-301.

25.

Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.

Kumari R, Lakhan R, Garg RK, Kalita J, Misra UK, Mittal B.

Indian J Hum Genet. 2011 May;17 Suppl 1:S32-40. doi: 10.4103/0971-6866.80357.

26.

Potential role of GABAA receptor subunit; GABRA6, GABRB2 and GABRR2 gene polymorphisms in epilepsy susceptibility and pharmacotherapy in North Indian population.

Kumari R, Lakhan R, Kalita J, Garg RK, Misra UK, Mittal B.

Clin Chim Acta. 2011 Jun 11;412(13-14):1244-8. doi: 10.1016/j.cca.2011.03.018. Epub 2011 Mar 21.

PMID:
21420396
27.

Association of alpha subunit of GABAA receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population.

Kumari R, Lakhan R, Kalita J, Misra UK, Mittal B.

Seizure. 2010 May;19(4):237-41. doi: 10.1016/j.seizure.2010.02.009. Epub 2010 Mar 30.

28.

Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epilepsy.

Lakhan R, Kalita J, Misra UK, Kumari R, Mittal B.

Synapse. 2010 May;64(5):403-8. doi: 10.1002/syn.20740.

PMID:
20034013
29.

A common polymorphism in the promoter of UCP2 is associated with obesity and hyperinsulenemia in northern Indians.

Srivastava N, Prakash J, Lakhan R, Agarwal CG, Pant DC, Mittal B.

Mol Cell Biochem. 2010 Apr;337(1-2):293-8. doi: 10.1007/s11010-009-0311-2. Epub 2009 Nov 12.

PMID:
19908126
30.

Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.

Lakhan R, Kumari R, Misra UK, Kalita J, Pradhan S, Mittal B.

Br J Clin Pharmacol. 2009 Aug;68(2):214-20. doi: 10.1111/j.1365-2125.2009.03437.x.

31.

No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.

Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B.

Epilepsy Behav. 2009 Jan;14(1):78-82. doi: 10.1016/j.yebeh.2008.08.019. Epub 2008 Oct 8.

PMID:
18812236
32.

Pathophysiology and genetics of obesity.

Srivastava N, Lakhan R, Mittal B.

Indian J Exp Biol. 2007 Nov;45(11):929-36. Review.

PMID:
18072536
33.
34.

Evaluation of p-nitrophenyl substituted semicarbazones for anticonvulsant properties.

Pandeya SN, Ponnilavarasan I, Pandey A, Lakhan R, Stables JP.

Pharmazie. 1999 Dec;54(12):923-5.

PMID:
10631757
35.

Potential CNS active agents. II--Studies of 4(3H)-quinazolinones.

Lakhan R, Singh RL.

Farmaco Sci. 1988 Sep;43(9):745-51.

PMID:
3229498
37.

Syntheses of some new 4(3H)-quinazolinones as potential CNS active agents.

Lakhan R, Singh OP.

Arch Pharm (Weinheim). 1985 Mar;318(3):228-38. No abstract available.

PMID:
2861799
38.

Synthesis of mercaptoquinazolinone derivatives as potential antimalarials.

Lakhan R.

Chem Pharm Bull (Tokyo). 1969 Nov;17(11):2357-61. No abstract available.

PMID:
5363291

Supplemental Content

Loading ...
Support Center